NGAL knockdown alleviated CSE-induced cellular senescence and reduced MMP2 and MMP9 expression in alveolar macrophages through the PI3K/Akt pathway

Eur J Med Res. 2025 Sep 23;30(1):850. doi: 10.1186/s40001-025-03222-x.

Abstract

Background: The accumulation of senescent cells has been identified as a key factor in the progression of emphysema. This study aimed to explore the role of neutrophil gelatinase-associated lipocalin (NGAL), a known mediator of COPD, in CSE-induced senescent alveolar macrophages.

Methods: NGAL and cellular senescence markers expression were quantified in the lungs of COPD patients. Meanwhile, double-immunofluorescence staining was used to detect NGAL levels in alveolar macrophages of COPD lung tissues. Using a cigarette smoke exposure (CSE)-induced cellular senescence model in MH-S cells. Effects of CSE on NGAL secretion in MH-S cells was assessed by ELISA. Western blotting analysis and SA-β-galactosidase staining were employed to measure cellular senescence markers. NGAL siRNA was used to knockdown NGAL expression. In addition, CCK8 was used to evaluate cell viability and proliferation of MH-S cells. The activation status of the PI3K/Akt pathway was determined by Western blotting.

Results: NGAL was elevated in alveolar macrophages from COPD patients compared with healthy controls. In vitro, exposure to CSE induced senescence in MH-S cells and concurrently increased NGAL secretion. Notably, NGAL knockdown attenuated CSE-induced senescence in MH-S cells via the PI3K/Akt pathway. Furthermore, NGAL downregulation significantly reversed CSE-suppressed MH-S cells proliferation and reduced MMP2 and MMP9 expression in senescent MH-S cells.

Conclusions: These findings indicate that CSE upregulates NGAL in alveolar macrophages, thereby driving cellular senescence and MMP production through PI3K/Akt pathway.

Keywords: Alveolar macrophage; Cellular senescence; Emphysema; NGAL.

MeSH terms

  • Aged
  • Cellular Senescence* / drug effects
  • Cellular Senescence* / genetics
  • Female
  • Gene Knockdown Techniques
  • Humans
  • Lipocalin-2* / genetics
  • Lipocalin-2* / metabolism
  • Macrophages, Alveolar* / drug effects
  • Macrophages, Alveolar* / metabolism
  • Macrophages, Alveolar* / pathology
  • Male
  • Matrix Metalloproteinase 2* / genetics
  • Matrix Metalloproteinase 2* / metabolism
  • Matrix Metalloproteinase 9* / genetics
  • Matrix Metalloproteinase 9* / metabolism
  • Middle Aged
  • Phosphatidylinositol 3-Kinases / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism
  • Pulmonary Disease, Chronic Obstructive* / genetics
  • Pulmonary Disease, Chronic Obstructive* / metabolism
  • Pulmonary Disease, Chronic Obstructive* / pathology
  • Signal Transduction

Substances

  • Lipocalin-2
  • Matrix Metalloproteinase 9
  • Proto-Oncogene Proteins c-akt
  • Phosphatidylinositol 3-Kinases
  • Matrix Metalloproteinase 2
  • LCN2 protein, human
  • MMP9 protein, human
  • MMP2 protein, human